ICLIO

The Institute for Clinical Immuno-Oncology (ICLIO) is an initiative of the Association of Community Cancer Centers (ACCC)

[ICLIO @ACCC_ICLIO]

ICLIO has now become a part of the ACCC Immuno-Oncology Institute. Visit https://t.co/HlOm5K675v to learn more, and please follow @ACCCBuzz for all further updates. #cancer #immunotherapy #immunooncology #IO #oncology

[ICLIO @ACCC_ICLIO]

On Demand Webinar: “Testing” the Relationship Between Pathologists, Surgeons and Oncologists https://t.co/setJadTdOh

[ICLIO @ACCC_ICLIO]

Learn more about the role that the microbiome could play in developing immunotherapies: https://t.co/CeA21oKyH9

[ICLIO @ACCC_ICLIO]

With advances in immunotherapy, it is time for us to reconsider how we approach survivorship: https://t.co/V8lC5oNBzF

[ICLIO @ACCC_ICLIO]

Read about best practices for immuno-oncology agents, including managing inventory, dispensing, and storage: https://t.co/I5oQeOFb3E

[ICLIO @ACCC_ICLIO]

Watch this replay of our webinar on the role of immuno-oncology biomarkers in lung cancer: https://t.co/HrG3iWiwkt #immunotherapy

[ICLIO @ACCC_ICLIO]

Our webinar on the role of the microbiome in immunotherapy is now available on-demand! https://t.co/BAIVEoMh5E

[ICLIO @ACCC_ICLIO]

.@AJMC_Journal summarized the findings of our latest report on immunotherapy, including top priorities for cancer centers and the most significant challenges they face in care delivery: https://t.co/W77R46nMWX

[ICLIO @ACCC_ICLIO]

We have dozens of webinars archived on a host of topics related to #immunotherapy. Check them all out here: https://t.co/3TcSYlPFcQ

[ICLIO @ACCC_ICLIO]

ICLIO Webinar: Managing Immune-Related Adverse Events: Learning from Case Studies https://t.co/2v42e8hSGR

[ICLIO @ACCC_ICLIO]

Congratulations to Advocate Medical Group, recipient of our 2017 ICLIO Innovator Award! https://t.co/5Bbht3JJff

[ICLIO @ACCC_ICLIO]

Browse through our most popular immuno-oncology resources: https://t.co/aCIa8EgQvP

[ICLIO @ACCC_ICLIO]

Creating a Supportive Treatment Environment for I-O Patients https://t.co/HT9EFjbExx

[ICLIO @ACCC_ICLIO]

Creating an I-O Program from the Ground Up https://t.co/WJHpoFRmdU

[ICLIO @ACCC_ICLIO]

The speed of advancement in immunotherapy makes it hard to keep up. Read about new immunotherapies and indications: https://t.co/5JKUVsYCz7

[ICLIO @ACCC_ICLIO]

ICLIO Webinar: Immuno-Oncology Management Best Practices 2.0 https://t.co/0kJ6Rt9YrN

[ICLIO @ACCC_ICLIO]

Managing Adverse Events Associated with I-O Agents e-Course https://t.co/IwcbqooNIy

[ICLIO @ACCC_ICLIO]

Managing Patient Expectations Webinar https://t.co/Q0Ep1UM1zs

[ICLIO @ACCC_ICLIO]

Effective management of immune-related adverse events (irAEs) necessitate the incorporation of non-oncology specialists into the I-O team: https://t.co/6W2TkQSLYP

[ICLIO @ACCC_ICLIO]

A Patient’s Perspective on Immuno-Oncology Treatment for Lung Cancer https://t.co/AnhPOyC4cY